ACR Appropriateness Criteria
Publication/Presentation Date
11-1-2016
Abstract
Stage I breast carcinoma is classified when an invasive breast carcinoma is ≤2 cm in diameter (T1), with no regional (axillary) lymph node metastases (N0) and no distant metastases (M0). The most common sites for metastases from breast cancer are the skeleton, lung, liver, and brain. In general, women and health care professionals prefer intensive screening and surveillance after a diagnosis of breast cancer. Screening protocols include conventional imaging such as chest radiography, bone scan, ultrasound of the liver, and MRI of brain. It is uncertain whether PET/CT will serve as a replacement for current imaging technologies. However, there are no survival or quality-of-life differences for women who undergo intensive screening and surveillance after a diagnosis of stage I breast carcinoma compared with those who do not. The ACR Appropriateness Criteria
Volume
13
Issue
11S
First Page
53
Last Page
53
ISSN
1558-349X
Published In/Presented At
Huynh, P. T., Lemeshko, S. V., Mahoney, M. C., Newell, M. S., Bailey, L., Barke, L. D., D'Orsi, C., Harvey, J. A., Hayes, M. K., Jokich, P. M., Lee, S. J., Lehman, C. D., Mainiero, M. B., Mankoff, D. A., Patel, S. B., Reynolds, H. E., Sutherland, M. L., & Haffty, B. G. (2016). ACR Appropriateness Criteria® Stage I Breast Carcinoma. Journal of the American College of Radiology : JACR, 13(11S), e53–e57. https://doi.org/10.1016/j.jacr.2016.09.024
Disciplines
Diagnosis | Medicine and Health Sciences | Other Analytical, Diagnostic and Therapeutic Techniques and Equipment | Radiology
PubMedID
27814824
Department(s)
Department of Radiology and Diagnostic Medical Imaging
Document Type
Article